IMUX vs REGN: Which Stock is Better?

Side-by-side comparison of Immunic Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

IMUX

Immunic Inc

$1.00

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricIMUXREGNWinner
Market Cap$130.46M$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze IMUX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IMUX or REGN a better investment?

Comparing IMUX and REGN: Immunic Inc has a market cap of $130.46M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IMUX and REGN?

IMUX (Immunic Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IMUX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IMUX or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for IMUX.

Which company is more profitable: IMUX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for IMUX.

Which is the larger company: IMUX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $130.46M for IMUX.

Should I buy IMUX or REGN in 2026?

Both IMUX and REGN have investment merit. IMUX trades at $1.00 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IMUX and REGN stock?

Key differences: Market Cap ($130.46M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons